Perturbation of the replication stress-ATR axis accelerates human erythroid differentiation but blocks terminal maturation
- 1University of Basel
Abstract
Replication stress (RS) can act as an input to differentiation: in erythroid and myeloid cells it is sufficient to accelerate commitment. Yet genotoxic chemotherapy, which imposes replication stress on the bone marrow can cause anemia; a frequent dose-limiting toxicity whose deficit of mature red cells is often attributed to progenitor depletion rather than to any effect on differentiation itself. Here, we ask how RS-induced accelerated commitment gives rise to impaired red cell output, using in vitro erythroid differentiation of cord-blood CD34+ progenitors perturbed with clinically relevant chemotherapy agents. We find that treated erythroblasts differentiate faster than controls but fail to mature, measured by lack of enucleated cells. Inhibition of ATR, but not ATM or DNA-PK, reproduces this phenotype. Mechanistically, single-cell profiling of drug-treated cells shows convergence on a transcriptional program, marked by loss of MYB and MYC activity. Treated cultures also accumulate aberrant late erythroblasts depleted for globin and heme programs and enriched for p53 and proteotoxic stress signatures. Together, these results propose that defective maturation is an alternative mechanism for chemotherapy-induced anemia, in addition to depletion of progenitors.
Related
- Impaired erythroid maturation in murine embryos upon loss of the preeclampsia-associated serine protease prostasin Prostasin loss impairs erythropoiesis
- ILF3 regulates erythroid differentiation: A single-cell transcriptomic analysis and cellular experiment
- H3-K27M mutation alters the dynamics of human hematopoietic stem cells and delays erythroid differentiation
- AIRE Deficiency Impairs Thymic Epithelial Progenitor Differentiation from Mouse Embryonic Stem Cells and Accelerates Type 1 Diabetes in NOD/Ltj Mice
- Replication-coupled maturation of readthrough late transcripts by a polyomavirus small T antigen
BibTeX
@misc{jaureguilozano2026perturbation,
title = {{Perturbation of the replication stress-ATR axis accelerates human erythroid differentiation but blocks terminal maturation}},
author = {J. Jauregui-Lozano and A. Kremer and K. D. Prummel and J. B. Zaugg},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.07.754672},
url = {https://www.biorxiv.org/content/10.64898/2026.10.07.754672v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Perturbation of the replication stress-ATR axis accelerates human erythroid differentiation but blocks terminal maturation
AU - J. Jauregui-Lozano
AU - A. Kremer
AU - K. D. Prummel
AU - J. B. Zaugg
PY - 2026
DA - 2026/10/07
PB - bioRxiv
DO - 10.64898/2026.10.07.754672
UR - https://www.biorxiv.org/content/10.64898/2026.10.07.754672v1
AB - Replication stress (RS) can act as an input to differentiation: in erythroid and myeloid cells it is sufficient to accelerate commitment. Yet genotoxic chemotherapy, which imposes replication stress on the bone marrow can cause anemia; a frequent dose-limiting toxicity whose deficit of mature red cells is often attributed to progenitor depletion rather than to any effect on differentiation itself. Here, we ask how RS-induced accelerated commitment gives rise to impaired red cell output, using in vitro erythroid differentiation of cord-blood CD34+ progenitors perturbed with clinically relevant chemotherapy agents. We find that treated erythroblasts differentiate faster than controls but fail to mature, measured by lack of enucleated cells. Inhibition of ATR, but not ATM or DNA-PK, reproduces this phenotype. Mechanistically, single-cell profiling of drug-treated cells shows convergence on a transcriptional program, marked by loss of MYB and MYC activity. Treated cultures also accumulate aberrant late erythroblasts depleted for globin and heme programs and enriched for p53 and proteotoxic stress signatures. Together, these results propose that defective maturation is an alternative mechanism for chemotherapy-induced anemia, in addition to depletion of progenitors.
ER -